Fungal Metabolite Cryptosporin Shows Antimalarial Promise With Low Resistance Risk
Researchers found that cryptosporin, a natural product from the fungus Acaromyces ingoldii, effectively kills malaria parasites through a novel mechanism involving oxidative stress rather than targeting mitochondria. The parasite develops resistance primarily through a mutation in an aquaglyceroporin gene and duplication of antioxidant genes, suggesting a low overall risk of widespread resistance. This discovery could lead to new antimalarial treatments with a different mechanism than existing drugs like artemisinin.
A preprint study describes cryptosporin's potent activity against both blood-stage and liver-stage malaria parasites with minimal toxicity to human cells. Unlike the drug atovaquone, cryptosporin does not target mitochondrial electron transport, suggesting a distinct mechanism of action. Through in vitro evolution and genomic analysis, researchers identified that parasites develop resistance via a specific mutation (F138Y) in the PfAQP aquaglyceroporin gene and duplications of superoxide dismutase genes, indicating the drug likely works by inducing oxidative stress. CRISPR/Cas9 experiments confirmed the aquaglyceroporin mutation is sufficient for resistance. The minimum inoculum of resistance—a measure of how easily resistance emerges—was low, suggesting cryptosporin may have favorable resistance development characteristics compared to some existing antimalarials.
What's missing
The study's own limitations warrant consideration: the resistance mechanism was identified through in vitro evolution under laboratory conditions, which may not fully reflect resistance development in natural parasite populations; clinical efficacy and safety in human patients remain untested; the study does not discuss potential cross-resistance with other antimalarial classes or the drug's pharmacokinetic properties in vivo.
What different sources said
- bioRxivCenter
Duplication of superoxide dismutase and a mutation in aquaglyceroporin mediates the sensitivity of Plasmodium falciparum to cryptosporin, a natural product derived from Acaromyces ingoldii
Related
Study Shows Statins Reduce Coenzyme Q in Brain Cells, Impairing Mitochondrial Function
A laboratory study found that statin drugs decrease coenzyme Q levels in astrocytes (brain support cells) by 30-40%, reducing their mitochondrial energy production and increasing oxidative stress. Astrocytes are critical for maintaining brain health and protecting neurons from damage. The findings suggest CoQ10 supplementation may help counteract these effects, though human clinical evidence remains limited.
Study reveals zebrafish larvae exhibit slowly fluctuating directional swim biases driven by internal dynamics
Researchers found that 5-day-old zebrafish larvae display changing directional swim preferences over many hours even in stable environments, contrary to classical models assuming constant individual biases. Computational analysis suggests these fluctuations arise from a non-stationary Markovian process with two independent internal input streams modulating swim direction repetition. The findings suggest animals possess intrinsic mechanisms for generating behavioral variability independent of external stimuli, with implications for understanding how internal states shape adaptive behavior.
Two Small Molecules Show Promise as Broad-Spectrum Coronavirus Inhibitors in Laboratory Study
Researchers found that sennoside A and ceftazidime, two small molecules, can inhibit RNA binding in the nucleocapsid proteins of SARS-CoV-2, SARS-CoV, and MERS-CoV in laboratory experiments. The nucleocapsid protein is highly conserved across coronaviruses and essential for viral replication, making it a potential drug target. The findings suggest these compounds could form the basis for pan-coronavirus antiviral therapies, though further development and clinical testing would be needed.